CONNETICS
Connetics Corporation engages in the development and commercialization of products for the medical dermatology market. The company markets two products, Luxiq and OLUX, both of which use the company's proprietary foam delivery system. Luxiq is considered as the company’s first dermatology product and OLUX treat psoriasis of the scalp. The products are classified as topical steroids. Luxiq competes in the mid-potency category of the topical steroids market and OLUX competes in the high- an... d super-high potency category of the topical steroids market. Connetics also owns the rights to Soriatane, an oral psoriasis drug originally developed by Switzerland-based La Roche Holding. Connetics follows what it refers to as its ""4:2:1"" development model, a strategy that calls for the company to have four products in development, two products in final stage trials mandated by the Food and Drug Administration (FDA), and one new FDA-approved product every year. Connetics Corporation was formerly known as Connective Therapeutics, Inc. It was incorporated in 1993 and is headquartered in Palo Alto, California.
CONNETICS
Industry:
Delivery Medical Therapeutics
Founded:
1989-01-01
Address:
Woolston, Canterbury, New Zealand
Country:
New Zealand
Website Url:
http://www.connetics.co.nz
Total Employee:
501+
Status:
Active
Contact:
+64 3 353 7200
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Domain Not Resolving Mobile Non Scaleable Content IPv6 ReCAPTCHA ASP.NET
Current Advisors List
Founder
Newest Events participated
Official Site Inspections
http://www.connetics.co.nz
- Host name: 206.189.148.185
- IP address: 206.189.148.185
- Location: Singapore
- Latitude: 1.314
- Longitude: 103.6839
- Timezone: Asia/Singapore
- Postal: 62
